510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K771346Substantially Equivalent

Ci-Trol Coagulation Controls II & III

Dade, Baxter Travenol Diagnostics, Inc., Mchenry IL / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K771346 is the FDA 510(k) clearance record for CI-TROL COAGULATION CONTROLS II & III, a class II device, cleared for Dade, Baxter Travenol Diagnostics, Inc. on under FDA product code GGN (Plasma, Coagulation Control). FDA records list 44 510(k) clearances for Dade, Baxter Travenol Diagnostics, Inc., from to . As of , FDA records show no recalls naming K771346.

Clearance record

Decision date
Received
(33 days to decision)
Product code
GGN Plasma, Coagulation Control
Regulation
21 CFR 864.5425
Device class
Class II
Review panel
Hematology
Applicant
Dade, Baxter Travenol Diagnostics, Inc. 803 N. Front St. Suite 3, Mchenry IL
Third party review
No

Clearances, product code GGN

Trailing 12 months

FDA records hold no clearances under product code GGN in the trailing twelve months.

FDA records show no clearances under product code GGN in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code GGN, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260